Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency (Q89846): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 16:42, 15 August 2026
This is an endocrine disorder that is an uncommon and potentially lethal form of congenital adrenal hyperplasia (CAH). This diagnosis is due to 3-beta-hydroxysteroid dehydrogenase deficiency.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_929626064 |
||
| English | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency |
This is an endocrine disorder that is an uncommon and potentially lethal form of congenital adrenal hyperplasia (CAH). This diagnosis is due to 3-beta-hydroxysteroid dehydrogenase deficiency. |
Statements
CID11:ID_929626064
0 references
dki-india-ID_929626064
0 references
Concluído
0 references
13 August 2026
0 references
